Afya Limited (AFYA)
Consumer Defensive
- Fundamental
- 4
- Sentiment
- 2
- Technical
- 2
Do Nothing: qualitativeScore is 2 (below the required floor of 3) — the strategy requires qualitativeScore ≥ 3 before any bullish entry — and avgDollarVolume20 ~$3.78M is below the $5M liquidity floor. No pullback limit qualifies (countertrend: price below the SMA50 and declining SMA200 with MACD < 0) and no breakout stop qualifies on negative momentum.
Company overview
Afya Limited is a leading medical education provider in Brazil, offering a wide range of educational products and services focused on the medical field. The company operates medical schools, preparatory courses, and advanced graduate studies, and provides digital health services through a subscription-based platform. Afya also offers programs in various health sciences and other disciplines such as business administration and engineering.
Fundamental
goodAfya shows strong profitability and cash generation with low valuation multiples, despite some regulatory and governance risks.
Afya pairs strong margins and cash generation with low valuation multiples (P/E 8.22, EV/EBITDA 5.26, free-cash-flow yield 17.88%). SEC disclosures emphasize dependence on Brazilian medical-education regulation and controlling-shareholder governance, but the latest interim filing indicates solid liquidity and no disclosed covenant issues. Overall this reads as a solid value + quality setup with some country/governance overhang.
Sentiment
weakSentiment is neutral with no actionable catalysts and cautious media coverage.
Dominant driver is the early-stage Yduqs potential business combination (announced, direction neutral — no in-window market reception) plus a fresh MEC-authorized medical-seat increase (announced 2026-09-18, not priced in, direction neutral); the 14-day media window is thin and slightly negative (aggregate polarity_score −0.05 on 2 aggregator-tier items, cautious 'Reduce' analyst tone, insider-selling mentions), the sentiment delta is indeterminate numerically (baseline had zero unique on-topic scored items; item-level read shows mild cooling from a constructive Q2/H1 baseline); Red-Flag Screen clean, no cap applied.
Technical
weakThe stock is in a downtrend with oversold conditions and no confirmed reversal.
AFYA (close 13.61 on 09-18; input snapshot 13.58) is in a persistent intermediate downtrend: price sits below the SMA20 (14.18), SMA50 (14.05) and SMA200 (14.42), and below the EMA9 (13.82) and EMA21 (13.99), after sliding from ~14.95 in early September toward the 52-week low zone (~13.00). Momentum confirms the bearish lean — MACD line -0.13 is below its signal (-0.04) and below zero with a negative histogram (-0.09); RSI 40.6 is weak; Williams %R -85.4 is deeply oversold; ADX 19.3 shows no trend strength in either direction. Volatility is modest: ATR14 0.44 (~3.2% of price), StdDev20 0.43. The read is a weak bearish / bounce-only oversold chart with no confirmed reversal — technicalScore 2. The action is Do Nothing regardless of the chart: qualitativeScore 2 fails the required floor of 3, and avgDollarVolume20 (~$3.78M) fails the $5M liquidity floor.
You’re looking at 2026-09-18 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Consumer Defensive
Not financial advice. For informational and educational purposes only.